Tag: Cancer
-
Investigating the Survival Benefit of Aggressive Procedure for Melanoma
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
-
Investigating the Financial Burden of Cancer Drugs on Medicare Patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare’s prescription drug benefit program, Part D, according to a new study.
-
Nanomedicine Opens Door to Precision Medicine for Brain Tumors
Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating glioblastoma.
-
PhD Student Explores Enzyme’s Role in Aggressive Brain Tumor
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
-
Stem Cell Transplant May Not Benefit Double-Hit Lymphoma Patients
A new study finds that patients with double-hit lymphoma who received autologous stem cell transplantation saw no survival benefit, compared to patients who did not undergo the procedure.
-
New Cancer Drug Can Prevent Reactions to Common Airborne Allergens
A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
-
Cold Virus, Stem Cells Tested to Destroy Deadly Brain Cancer
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
-
Evaluating Active Surveillance in Prostate Cancer
Younger men with prostate cancer had a decreased risk of cancer progression while under active surveillance, compared to men older than 60, according to a recent study.
-
Student Studies the Roots of Glioblastoma
Read a Q-and-A with Jasmine May, a fifth-year student in the Medical Scientist Training Program, who studies the pathophysiology of glioblastoma.
-
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
